Training - EthosCE - DTD

Pediatric differentiated thyroid cancer (DTC) patients frequently present with lymph node and/or distant (lung) metastases. Such patients warrant an aggressive treatment consisting of surgical removal of all surgically accessible local metastases as well as further treatment with one or more courses of radioiodine therapy (RAI). It is still a subject of debate in literature how much I-131 should be administered to pediatric patients. Patients can either be given a fixed (possibly body weight adjusted) activity or a dosimetry based activity, which is often considerably higher.
 

Target Audience

Endocrinologists/Pediatric  Endocrinologists

Radiologists

Learning Objectives

Here, we will present a typical case of a pediatric patient who was treated using a dosimetric approach. Then we will discuss the basis of dosimetry and the procedures involved, followed by a discussion of when to use dosimetric RAI as well as the pros and cons of the various approaches in pediatric patients.

Course summary
Available credit: 
  • 0.00 AMA PRA Category 1 Credit™
Course opens: 
11/30/2018
Course expires: 
11/30/2021
Cost:
$0.00

D. Disbrow - Director, CME

The (NAME OF YOUR ORGANIZATION) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Available Credit

  • 0.00 AMA PRA Category 1 Credit™

Accreditation Period

Course opens: 
11/30/2018
Course expires: 
11/30/2021

Price

Cost:
$0.00
Please login or register to take this course.